为您找到相关结果约118个

你是不是要搜索 期刊GEMOX 点击跳转

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer

(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system

EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on

Comparison of the efficacy and impact of GEMOX and GDP in the treatment of patients with non-Hodgkin's

A novel combination of GEMOX and apatinib in treatment of unresectable or metastatic cholangiocellular

GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: preliminary safety results

Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised

SHR-1210 combined with GEMOX as first-line treatment in patients with advanced biliary tract cancer

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer:

Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic

Triple therapy in biliary tract cancers: GemOX plus immune checkpoint inhibitor in combination with lenvatinib

GEMOX: An Active Regimen for the Treatment of Luminal and Human Epidermal Growth Factor Receptor 2-Positive

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced

为您找到相关结果约118个

共118条页码: 1/8页15条/页